Penumbra (PEN) EBT Margin Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Penumbra | 12.52 Bn | 11.91 Bn | 253.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 376.00 |
| Dec 31, 2025 | 1,682.00 |
| Sep 30, 2025 | 2,781.00 |
| Jun 30, 2025 | 2,955.00 |
| Mar 31, 2025 | 1,407.00 |
| Dec 31, 2024 | 596.00 |
| Sep 30, 2024 | 392.00 |
| Jun 30, 2024 | -3,608.00 |
| Mar 31, 2024 | -402.00 |
| Dec 31, 2023 | 732.00 |
| Sep 30, 2023 | 2,272.00 |
| Jun 30, 2023 | -134.00 |
| Mar 31, 2023 | -80.00 |
| Dec 31, 2022 | -84.00 |
| Sep 30, 2022 | -6.00 |
| Jun 30, 2022 | 58.00 |
| Mar 31, 2022 | -11.00 |
| Dec 31, 2021 | -1,800.00 |
| Sep 30, 2021 | 572.00 |
| Jun 30, 2021 | 613.00 |
| Mar 31, 2021 | 371.00 |
| Dec 31, 2020 | -375.00 |
| Sep 30, 2020 | -1,719.00 |
| Jun 30, 2020 | -633.00 |
| Mar 31, 2020 | -1,143.00 |
| Dec 31, 2019 | 691.00 |
| Sep 30, 2019 | 806.00 |
| Jun 30, 2019 | 840.00 |
| Mar 31, 2019 | 240.00 |